. | Pilocytic astrocytoma . | Astrocytoma . | Oligodendroglioma . | Medulloblastoma . | Malignant glioma . | Metastasis . | Primary CNS lymphoma . | Germ cell tumour . |
---|---|---|---|---|---|---|---|---|
Peak age | 10–30 yr | 20–40 yr | 20–50 yr | 1–20 yr | 40–70 yr | 50–80 yr | 50–70 yr | 10–30 yr |
Site | Usually cerebral or midline cerebellar | Adult cerebral; child cerebellar | Frontotemporal | Cerebellum, IV ventricle | Cerebral | Anywhere | Periventricular, anywhere | Pineal, suprasellar |
Single/multiple | Single | Single | Single | Single/CSF | 95% single | 33% single | 60% single CSF>20% Vitreous>20% | 90% single CSF>20% |
Usual characteristics | ||||||||
Borders | Well demarcated | Diffuse/infiltrating | Well defined | Well defined | Serpiginous | Well defined | Indistinct | Distinct |
Cysts | Common | Uncommon | Uncommon | Uncommon | Occ. necrotic | Occasionally | Nil | Occasionally |
Calcification | 10–40% | 5–10% | 50% | Nil | <5% | <3% | Nil | 10–15% |
Peritumoral oedema | Nil or mild | Mild | Mild | Moderate | Moderate | Moderate/severe | Mild/severe | Nil/mild |
Mass effect | Nil or mild | Mild | Mild/moderate | Moderate | Moderate | Moderate/severe | Mild/severe | Nil/mild |
Investigations | ||||||||
CT | Low density | Low density | Low density | Occ. high density | Low density | Low density | Occ. high density | Low density |
Enhancing nodule | No enhancement | No enhancement | Enhancement | Border enhances | Uniform/border | Uniform/border | Uniform | |
T1-MRI | Iso/hyperintense | Hypointense | Hypointense | Hypointense | Hypointense | Hypointense | Hyper/isointense | Iso/hypointense |
T1 Gad-MRI | Enhancing nodule | No enhancement | No enhancement | Enhancement | Border enhances | Uniform/border | Uniform/border | Uniform |
T2-MRI | Hyperintense | Hyperintense | Hyperintense | Hyperintense | Hyperintense | Hyperintense | Hyperintense | Hyperintense |
Other helpful tests | – | – | – | MRI spine | – | Chest/abdo. CT | Slit-lamp (eyes) | CSF |
CSF | Tumour markers | CSF | Tumour markers | |||||
Differential diagnosis | Abscess | Multiple sclerosis | Meningioma | Astrocytoma | Abscess | Stroke | Multiple sclerosis | Meningioma |
Malig. glioma | Infarct | AVM | Malig. glioma | Stroke | Abscess | Sarcoid | PNET | |
Ganglioglioma | Oligodendroglioma | Astrocytoma | Lymphoma | Metastasis | Malig. glioma | Metastasis | Malig. glioma | |
Craniopharyngioma | Malig. glioma | Craniopharyngioma | Germinoma | Oligodendroglioma | Lymphoma | Malig. glioma | Metastasis | |
Germinoma | Malig. glioma | Lymphoma | Toxoplasmosis |
. | Pilocytic astrocytoma . | Astrocytoma . | Oligodendroglioma . | Medulloblastoma . | Malignant glioma . | Metastasis . | Primary CNS lymphoma . | Germ cell tumour . |
---|---|---|---|---|---|---|---|---|
Peak age | 10–30 yr | 20–40 yr | 20–50 yr | 1–20 yr | 40–70 yr | 50–80 yr | 50–70 yr | 10–30 yr |
Site | Usually cerebral or midline cerebellar | Adult cerebral; child cerebellar | Frontotemporal | Cerebellum, IV ventricle | Cerebral | Anywhere | Periventricular, anywhere | Pineal, suprasellar |
Single/multiple | Single | Single | Single | Single/CSF | 95% single | 33% single | 60% single CSF>20% Vitreous>20% | 90% single CSF>20% |
Usual characteristics | ||||||||
Borders | Well demarcated | Diffuse/infiltrating | Well defined | Well defined | Serpiginous | Well defined | Indistinct | Distinct |
Cysts | Common | Uncommon | Uncommon | Uncommon | Occ. necrotic | Occasionally | Nil | Occasionally |
Calcification | 10–40% | 5–10% | 50% | Nil | <5% | <3% | Nil | 10–15% |
Peritumoral oedema | Nil or mild | Mild | Mild | Moderate | Moderate | Moderate/severe | Mild/severe | Nil/mild |
Mass effect | Nil or mild | Mild | Mild/moderate | Moderate | Moderate | Moderate/severe | Mild/severe | Nil/mild |
Investigations | ||||||||
CT | Low density | Low density | Low density | Occ. high density | Low density | Low density | Occ. high density | Low density |
Enhancing nodule | No enhancement | No enhancement | Enhancement | Border enhances | Uniform/border | Uniform/border | Uniform | |
T1-MRI | Iso/hyperintense | Hypointense | Hypointense | Hypointense | Hypointense | Hypointense | Hyper/isointense | Iso/hypointense |
T1 Gad-MRI | Enhancing nodule | No enhancement | No enhancement | Enhancement | Border enhances | Uniform/border | Uniform/border | Uniform |
T2-MRI | Hyperintense | Hyperintense | Hyperintense | Hyperintense | Hyperintense | Hyperintense | Hyperintense | Hyperintense |
Other helpful tests | – | – | – | MRI spine | – | Chest/abdo. CT | Slit-lamp (eyes) | CSF |
CSF | Tumour markers | CSF | Tumour markers | |||||
Differential diagnosis | Abscess | Multiple sclerosis | Meningioma | Astrocytoma | Abscess | Stroke | Multiple sclerosis | Meningioma |
Malig. glioma | Infarct | AVM | Malig. glioma | Stroke | Abscess | Sarcoid | PNET | |
Ganglioglioma | Oligodendroglioma | Astrocytoma | Lymphoma | Metastasis | Malig. glioma | Metastasis | Malig. glioma | |
Craniopharyngioma | Malig. glioma | Craniopharyngioma | Germinoma | Oligodendroglioma | Lymphoma | Malig. glioma | Metastasis | |
Germinoma | Malig. glioma | Lymphoma | Toxoplasmosis |
abdo., Abdominal; AVM, arterio-venous malformation; CNS, central nervous system; CSF, cerebrospinal fluid; Gad, gadolinium; Malig., malignant; Occ., occasional(ly); PNET, primitive neuro-ectodermal tumour.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.